Expression of Corticotropin-Releasing Hormone and Its Receptors May Be Associated With Survival Rate in Pancreatic Cancer-Reference-Cited by-同舟云学术

Expression of Corticotropin-Releasing Hormone and Its Receptors May Be Associated With Survival Rate in Pancreatic Cancer

Published:2023 Issue:1 Volume:2 Page:147-155
ISSN:2772-5723
Container-title:Gastro Hep Advances
language:en
Short-container-title:Gastro Hep Advances

Author:

Sato Naoko^ORCID,Motoi Fuyuhiko,Tajiki Hana,Kawaguchi Kei,Ohtsuka Hideo,Takadate Tatuyuki,Nakagawa Kei,Takagi Kiyoshi,Suzuki Takashi,Katayose Yu,Fukudo Shin,Unno Michiaki

Funder

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Reference34 articles.

1. The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017;Lancet Gastroenterol Hepatol,2019

2. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin;Vale;Science,1981

3. The corticotropin-releasing factor (CRF) family of peptides as local modulators of adrenal function;Tsatsanis;Cell Mol Life Sci,2007

4. Physiology and neurobiology of stress and adaptation: central role of the brain;McEwen;Physiol Rev,2007

5. Hypothalamic-pituitary-adrenal axis in gastrointestinal physiology. Chapter 28, Section II: Neurogastroenterology. Wood JD Section Editor;Fukudo,2012

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer;Clinical Cancer Research;2023-10-26